Copy Number Variation Sequencing for Comprehensive Diagnosis of Chromosome Disease Syndromes  Desheng Liang, Ying Peng, Weigang Lv, Linbei Deng, Yanghui.

Slides:



Advertisements
Similar presentations
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Advertisements

A Genome-Wide High-Resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation  Lu Wang, Mamta Rao,
Ane Y. Schmidt, Thomas v. O. Hansen, Lise B
High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer  Yu Wu, Jamie R. Schoenborn, Colm Morrissey, Jing Xia, Sandy Larson, Lisha.
The clinical utility of next-generation sequencing for identifying chromosome disease syndromes in human embryos  Junmei Fan, Li Wang, Hui Wang, Minyue.
Nonrecurrent 17p11.2p12 Rearrangement Events that Result in Two Concomitant Genomic Disorders: The PMP22-RAI1 Contiguous Gene Duplication Syndrome  Bo.
Haley J. Abel, Hussam Al-Kateb, Catherine E. Cottrell, Andrew J
Laila C. Schenkel, Charles Schwartz, Cindy Skinner, David I
Comprehensive Screening of Gene Copy Number Aberrations in Formalin-Fixed, Paraffin-Embedded Solid Tumors Using Molecular Inversion Probe–Based Single-
Microarray-Based Comparative Genomic Hybridization Using Sex-Matched Reference DNA Provides Greater Sensitivity for Detection of Sex Chromosome Imbalances.
Improved Diagnosis of Inherited Retinal Dystrophies by High-Fidelity PCR of ORF15 followed by Next-Generation Sequencing  Jianli Li, Jia Tang, Yanming.
Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Ronald van Marion, Niels M
Robustness of Amplicon Deep Sequencing Underlines Its Utility in Clinical Applications  Vera Grossmann, Andreas Roller, Hans-Ulrich Klein, Sandra Weissmann,
Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic.
Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma  Esther M. van Wezel, Danny Zwijnenburg, Lily.
Harvey A. Greisman, Noah G. Hoffman, Hye Son Yi 
Pyrosequencing Is an Accurate and Reliable Method for the Analysis of Heteroplasmy of the A3243G Mutation in Patients with Mitochondrial Diabetes  Jing-bin.
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma 
Diagnostic Genome Profiling in Mental Retardation
Comparison of High-Resolution Melting Analysis, TaqMan Allelic Discrimination Assay, and Sanger Sequencing for Clopidogrel Efficacy Genotyping in Routine.
Clinical Relevance of Sensitive and Quantitative STAT3 Mutation Analysis Using Next- Generation Sequencing in T-Cell Large Granular Lymphocytic Leukemia 
Molecular Diagnosis of Autosomal Dominant Polycystic Kidney Disease Using Next- Generation Sequencing  Adrian Y. Tan, Alber Michaeel, Genyan Liu, Olivier.
Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis.
Christopher M. Watson, Nick Camm, Laura A
Hou-Sung Jung, Gregory J. Tsongalis, Joel A. Lefferts 
A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2  Jianli Li, Hongzheng Dai, Yanming Feng, Jia Tang, Stella Chen,
Development and Verification of an RNA Sequencing (RNA-Seq) Assay for the Detection of Gene Fusions in Tumors  Jennifer L. Winters, Jaime I. Davila, Amber.
A Tumor Sorting Protocol that Enables Enrichment of Pancreatic Adenocarcinoma Cells and Facilitation of Genetic Analyses  Zachary S. Boyd, Rajiv Raja,
Jennifer Kerkhof, Laila C
High-Resolution Mapping of Genotype-Phenotype Relationships in Cri du Chat Syndrome Using Array Comparative Genomic Hybridization  Xiaoxiao Zhang, Antoine.
A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families  Wenhui L.
Genomic Variation by Whole-Genome SNP Mapping Arrays Predicts Time-to-Event Outcome in Patients with Chronic Lymphocytic Leukemia  Carmen D. Schweighofer,
Andrea Gaedigk, Amanda K. Riffel, J. Steven Leeder 
Eric Samorodnitsky, Jharna Datta, Benjamin M
The Fine-Scale and Complex Architecture of Human Copy-Number Variation
A Genome-Wide High-Resolution Array-CGH Analysis of Cutaneous Melanoma and Comparison of Array-CGH to FISH in Diagnostic Evaluation  Lu Wang, Mamta Rao,
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel Sequencing  Colin C. Pritchard, Christina Smith,
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies  Michael J. Kluk, R. Coleman Lindsley,
Comprehensive Diagnostic Testing for Stereocilin
Catherine E. Keegan, Anthony A. Killeen 
Rapid Detection of TEM-Type Extended-Spectrum β-Lactamase (ESBL) Mutations Using Lights-On/Lights-Off Probes with Single-Stranded DNA Amplification  Kenneth.
A Multiplex qPCR Gene Dosage Assay for Rapid Genotyping and Large-Scale Population Screening for Deletional α-Thalassemia  Wanjun Zhou, Ge Wang, Xuefeng.
S. Hussain Askree, Shika Dharamrup, Lawrence N. Hjelm, Bradford Coffee 
Gerald B. W. Wertheim, Catherine Smith, Maria E
Detailed Characterization of Alterations of Chromosomes 7, 9, and 10 in Glioblastomas as Assessed by Single-Nucleotide Polymorphism Arrays  Inês Crespo,
Technical Validation of a Next-Generation Sequencing Assay for Detecting Clinically Relevant Levels of Breast Cancer–Related Single-Nucleotide Variants.
Serum DNA Motifs Predict Disease and Clinical Status in Multiple Sclerosis  Julia Beck, Howard B. Urnovitz, Marina Saresella, Domenico Caputo, Mario Clerici,
Molecular Inversion Probe Array for the Genetic Evaluation of Stillbirth Using Formalin- Fixed, Paraffin-Embedded Tissue  Leslie R. Rowe, Harshwardhan.
Detection and Discrimination between Deletional and Non-Deletional Prader-Willi and Angelman Syndromes by Methylation-Specific PCR and Quantitative Melting.
Nonrecurrent 17p11.2p12 Rearrangement Events that Result in Two Concomitant Genomic Disorders: The PMP22-RAI1 Contiguous Gene Duplication Syndrome  Bo.
Bassem A. Bejjani, Lisa G. Shaffer 
Defining Ploidy-Specific Thresholds in Array Comparative Genomic Hybridization to Improve the Sensitivity of Detection of Single Copy Alterations in Cell.
A Novel Long-Range PCR Sequencing Method for Genetic Analysis of the Entire PKD1 Gene  Ying-Cai Tan, Alber Michaeel, Jon Blumenfeld, Stephanie Donahue,
Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement.
Next-Generation Sequencing for Infectious Disease Diagnosis and Management  Martina I. Lefterova, Carlos J. Suarez, Niaz Banaei, Benjamin A. Pinsky  The.
Analytical Validation of a Personalized Medicine APOL1 Genotyping Assay for Nondiabetic Chronic Kidney Disease Risk Assessment  Jinglan Zhang, Anastasia.
High-Resolution Molecular Characterization of 15q11-q13 Rearrangements by Array Comparative Genomic Hybridization (Array CGH) with Detection of Gene Dosage 
A DNA Replication Mechanism for Generating Nonrecurrent Rearrangements Associated with Genomic Disorders  Jennifer A. Lee, Claudia M.B. Carvalho, James.
Feras M. Hantash, Arlene Rebuyon, Mei Peng, Joy B
A Pyrosequencing-Based Assay for the Rapid Detection of the 22q11
Large Clinically Consequential Imbalances Detected at the Breakpoints of Apparently Balanced and Inherited Chromosome Rearrangements  Sarah T. South,
Molecular Analysis of a Deletion Hotspot in the NRXN1 Region Reveals the Involvement of Short Inverted Repeats in Deletion CNVs  Xiaoli Chen, Yiping Shen,
Custom Design of a GeXP Multiplexed Assay Used to Assess Expression Profiles of Inflammatory Gene Targets in Normal Colon, Polyp, and Tumor Tissue  Janice.
Characterization of a Recurrent Novel Large Duplication in the Cystic Fibrosis Transmembrane Conductance Regulator Gene  Feras M. Hantash, Joy B. Redman,
Volume 41, Issue 2, Pages (January 2011)
C. E. Browne, N. R. Dennis, E. Maher, F. L. Long, J. C. Nicholson, J
Next-Generation Sequencing of Duplication CNVs Reveals that Most Are Tandem and Some Create Fusion Genes at Breakpoints  Scott Newman, Karen E. Hermetz,
Development of a Novel Next-Generation Sequencing Assay for Carrier Screening in Old Order Amish and Mennonite Populations of Pennsylvania  Erin L. Crowgey,
Presentation transcript:

Copy Number Variation Sequencing for Comprehensive Diagnosis of Chromosome Disease Syndromes  Desheng Liang, Ying Peng, Weigang Lv, Linbei Deng, Yanghui Zhang, Haoxian Li, Pu Yang, Jianguang Zhang, Zhuo Song, Genming Xu, David S. Cram, Lingqian Wu  The Journal of Molecular Diagnostics  Volume 16, Issue 5, Pages 519-526 (September 2014) DOI: 10.1016/j.jmoldx.2014.05.002 Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 1 Performance of CNV-seq on low template DNA samples. Chromosome 4 CNV-seq profiles for duplicate 10- and 50-ng 46,XX and 46,XX,4p16.1-pter genomic DNA samples. CNV-seq profiles are log2 values of the normalized sequencing read densities (y axis) versus the number of sequential 5-kb sliding 60-kb sequencing bins (x axis). The upper [log2 (3/2)] and lower [log2 (1/2)] dashed lines indicate 100% (one copy) chromosome gain (duplication) and loss (deletion), respectively. The mean log2 value for CNV (blue tracking line), regions of repetitive sequences (red bars), and the centromere (black bars) are also shown. Input DNA of 50 ng was more optimal for accurate assessment of the 8.92-Mb 4p16.1-pter deletion (arrows). The Journal of Molecular Diagnostics 2014 16, 519-526DOI: (10.1016/j.jmoldx.2014.05.002) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 2 Mate pair sequencing to confirm the breakpoints of the 0.22-Mb Xp22.2 and 0.08-Mb 6q26 deletions originally identified by CNV-seq. Mate pair sequence results of the 5-kb fragments spanning the deletion interval were used to define the approximate coordinates of the deleted regions relative to the hg19 reference genome and design PCR primers on either side of the breakpoints. Sanger sequencing of the bridging PCR products mapped both deletion sizes and breakpoints to the precise single nucleotide (arrow). The Xp22.2 and 6q26 deletions harbored by patients suspected to manifest X-linked Pelizaeus-Merzbacher disease and Parkinson disease were, therefore, confirmed by full and partial loss of PLP1 and PARK2 gene sequences, respectively. The Journal of Molecular Diagnostics 2014 16, 519-526DOI: (10.1016/j.jmoldx.2014.05.002) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 3 Reproduciblity of CNV-seq for CNV. Triplicate CNV profiles showing the 0.22-Mb Xp22.2 and 0.08-Mb 6q26 deletions. CNV-seq profiles are log2 values of the normalized sequencing read densities (y axis) versus the number of sequential 5-kb sliding 60-kb sequencing bins (x axis). The upper [log2 (3/2)] and lower [log2 (1/2)] dashed lines indicate 100% (one copy) chromosome gain (duplication) and loss (deletion), respectively. The mean log2 value for CNV (blue tracking line), regions of repetitive sequences (red bars), and the centromere (black bars) are also shown. Both deletions (arrows) were reproducibly detected by CNV-seq in three independent replicate samples and showed the expected copy number change. The Journal of Molecular Diagnostics 2014 16, 519-526DOI: (10.1016/j.jmoldx.2014.05.002) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 4 Examples of matching SNP array and CNV-seq profiles for four classical chromosome disease syndromes. The chromosome location and size of the CNVs identified by both methods was virtually identical. See Supplemental Table S1 for details of each CNV. The Journal of Molecular Diagnostics 2014 16, 519-526DOI: (10.1016/j.jmoldx.2014.05.002) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Figure 5 CNV-seq diagnosis of ring chromsomes 14, 22, and 18. CNV-seq profiles and matching karotypes. CNV-seq profiles are log2 values of the normalized sequencing read densities (y axis) versus the number of sequential 5-kb sliding 60-kb sequencing bins (x axis). The upper [log2 (3/2)] and lower [log2 (1/2)] dashed lines indicate 100% (one copy) chromosome gain (duplication) and loss (deletion), respectively. The mean log2 value for CNV (blue tracking line), regions of repetitive sequences (red bars), and the centromere (black bars) are also shown. CNV-seq precisely mapped and sized the terminal breakpoints. The Journal of Molecular Diagnostics 2014 16, 519-526DOI: (10.1016/j.jmoldx.2014.05.002) Copyright © 2014 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions